GERALD SIGUA: Open Payments
NPI 1467987461 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,128 in 28 payments from 15 companies in 2025. Trend: 2023 $346 · 2024 $520 · 2025 $1,128
Food & beverage: $1,128
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $199 |
| Madrigal Pharmaceuticals | 1 | $142 |
| Amgen Inc. | 1 | $137 |
| Alkermes, Inc. | 5 | $122 |
| COLOPLAST CORP | 1 | $113 |
| Otsuka America Pharmaceutical, Inc. | 4 | $103 |
| Neurocrine BioSciences, Inc. | 2 | $69 |
| ABBVIE INC. | 3 | $51 |
| Almatica Pharma LLC | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
Products named: REZDIFFRA, KRYSTEXXA, Titan, REXULTI, BLUJEPA, ARISTADA, INGREZZA, VRAYLAR.
Industry payments across FL — which companies pay providers there.
